Insider Trading activities of Visicu Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Visicu Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Visicu Inc since year 2005. Table 2 shows the detailed insider transactions of Visicu Inc since 2005. The reporting company's ticker symbol is EICU. The reporting company's CIK number is 1166463.
The total value of stock buying since 2005 is $320,820.
The total value of stock sales since 2005 is $20,345,601.
The total value of stock option exercises since 2005 is $107,196.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Visicu Inc (EICU).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2007-10 0 $0 8,100 $64,800 8,000 $7,148
2007-09 0 $0 18,000 $144,000 8,000 $7,150
2007-08 0 $0 18,000 $144,000 8,000 $7,149
2007-07 0 $0 18,000 $164,898 8,000 $7,150
2007-06 0 $0 32,700 $320,731 9,300 $9,489
2007-05 0 $0 36,300 $339,179 9,700 $10,210
2007-04 0 $0 46,592 $395,336 17,000 $16,100
2007-03 0 $0 1,224 $9,792 0 $0
2007-02 0 $0 29,000 $302,620 9,000 $8,950
2007-01 0 $0 39,200 $408,864 9,000 $8,950
2006-12 0 $0 29,000 $290,270 9,000 $8,950
2006-11 10,000 $92,820 1,736,000 $17,761,111 29,000 $15,950
2006-04 14,250 $228,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Visicu Inc insiders (EICU)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2007-10-12 Estrada Vincent E (Sr VP and CFO) Sale 2,838 8.00 22,704
2007-10-12 Estrada Vincent E (Sr VP and CFO) Option Ex 2,838 1.80 5,108
2007-10-12 Sample Frank T (Chairman and CEO) Sale 4,729 8.00 37,832
2007-10-12 Sample Frank T (Chairman and CEO) Option Ex 4,729 .35 1,655
2007-10-08 Sample Frank T (Chairman and CEO) Sale 171 8.00 1,368
2007-10-08 Sample Frank T (Chairman and CEO) Option Ex 171 .35 59
2007-10-05 Breslow Michael J (EVP Clinical R&D) Sale 100 8.00 800
2007-10-05 Estrada Vincent E (Sr VP and CFO) Sale 162 8.00 1,296
2007-10-05 Estrada Vincent E (Sr VP and CFO) Option Ex 162 1.80 291
2007-10-05 Sample Frank T (Chairman and CEO) Sale 100 8.00 800
2007-10-05 Sample Frank T (Chairman and CEO) Option Ex 100 .35 35
2007-09-21 Breslow Michael J (EVP Clinical R&D) Sale 5,000 8.00 40,000
2007-09-21 Rosenfeld Brian A (EVP and CMO) Sale 5,000 8.00 40,000
2007-09-21 Estrada Vincent E (Sr VP and CFO) Sale 3,000 8.00 24,000
2007-09-21 Estrada Vincent E (Sr VP and CFO) Option Ex 3,000 1.80 5,400
2007-09-21 Sample Frank T (Chairman and CEO) Sale 5,000 8.00 40,000
2007-09-21 Sample Frank T (Chairman and CEO) Option Ex 5,000 .35 1,750
2007-08-07 Breslow Michael J (EVP Clinical R&D) Sale 4,022 8.00 32,176
2007-08-07 Rosenfeld Brian A (EVP and CMO) Sale 3,600 8.00 28,800
2007-08-07 Estrada Vincent E (Sr VP and CFO) Sale 992 8.00 7,936
2007-08-07 Estrada Vincent E (Sr VP and CFO) Option Ex 992 1.80 1,785
2007-08-07 Sample Frank T (Chairman and CEO) Sale 3,400 8.00 27,200
2007-08-07 Sample Frank T (Chairman and CEO) Option Ex 3,400 .35 1,190
2007-08-06 Breslow Michael J (EVP Clinical R&D) Sale 978 8.00 7,824
2007-08-06 Rosenfeld Brian A (EVP and CMO) Sale 1,400 8.00 11,200
2007-08-06 Estrada Vincent E (Sr VP and CFO) Sale 2,008 8.00 16,064
2007-08-06 Estrada Vincent E (Sr VP and CFO) Option Ex 2,008 1.80 3,614
2007-08-06 Sample Frank T (Chairman and CEO) Sale 1,600 8.00 12,800
2007-08-06 Sample Frank T (Chairman and CEO) Option Ex 1,600 .35 560
2007-07-05 Sample Frank T (Chairman and CEO) Sale 5,000 9.24 46,210
2007-07-05 Sample Frank T (Chairman and CEO) Option Ex 5,000 .35 1,750
2007-07-02 Breslow Michael J (EVP Clinical R&D) Sale 5,000 9.13 45,660
2007-07-02 Rosenfeld Brian A (EVP and CMO) Sale 5,000 9.13 45,650
2007-07-02 Estrada Vincent E (Sr VP and CFO) Sale 3,000 9.13 27,378
2007-07-02 Estrada Vincent E (Sr VP and CFO) Option Ex 3,000 1.80 5,400
2007-06-08 Breslow Michael J (EVP Clinical R&D) Sale 3,250 10.00 32,500
2007-06-08 Rosenfeld Brian A (EVP and CMO) Sale 3,350 10.00 33,500
2007-06-08 Estrada Vincent E (Sr VP and CFO) Sale 31 10.00 310
2007-06-08 Estrada Vincent E (Sr VP and CFO) Option Ex 31 1.80 55
2007-06-06 Sample Frank T (Chairman and CEO) Sale 5,000 9.64 48,175
2007-06-06 Sample Frank T (Chairman and CEO) Option Ex 5,000 .35 1,750
2007-06-01 Breslow Michael J (EVP Clinical R&D) Sale 8,450 9.79 82,750
2007-06-01 Rosenfeld Brian A (EVP and CMO) Sale 8,350 9.79 81,729
2007-06-01 Estrada Vincent E (Sr VP and CFO) Sale 4,269 9.78 41,767
2007-06-01 Estrada Vincent E (Sr VP and CFO) Option Ex 4,269 1.80 7,684
2007-05-31 Breslow Michael J (EVP Clinical R&D) Sale 5,700 10.00 57,000
2007-05-31 Rosenfeld Brian A (EVP and CMO) Sale 5,043 10.00 50,430
2007-05-31 Estrada Vincent E (Sr VP and CFO) Sale 700 10.00 7,000
2007-05-31 Estrada Vincent E (Sr VP and CFO) Option Ex 700 1.80 1,260
2007-05-30 Breslow Michael J (EVP Clinical R&D) Sale 2,600 10.00 26,000
2007-05-30 Rosenfeld Brian A (EVP and CMO) Sale 3,257 10.00 32,570
2007-05-30 Estrada Vincent E (Sr VP and CFO) Sale 1,000 10.00 10,000
2007-05-30 Estrada Vincent E (Sr VP and CFO) Option Ex 1,000 1.80 1,800
2007-05-02 Sample Frank T (Chairman and CEO) Sale 5,000 8.74 43,675
2007-05-02 Sample Frank T (Chairman and CEO) Option Ex 5,000 .35 1,750
2007-05-01 Breslow Michael J (EVP Clinical R&D) Sale 5,000 8.63 43,150
2007-05-01 Rosenfeld Brian A (EVP and CMO) Sale 5,000 8.68 43,380
2007-05-01 Estrada Vincent E (Sr VP and CFO) Sale 3,000 8.66 25,974
2007-05-01 Estrada Vincent E (Sr VP and CFO) Option Ex 3,000 1.80 5,400
2007-04-30 Breslow Michael J (EVP Clinical R&D) Sale 5,000 10.06 50,300
2007-04-30 Rosenfeld Brian A (EVP and CMO) Sale 5,000 10.06 50,300
2007-04-30 Estrada Vincent E (Sr VP and CFO) Sale 1,000 10.00 10,000
2007-04-30 Estrada Vincent E (Sr VP and CFO) Option Ex 1,000 1.80 1,800
2007-04-20 Breslow Michael J (EVP Clinical R&D) Sale 9,592 8.00 76,736
2007-04-20 Rosenfeld Brian A (EVP and CMO) Sale 10,000 8.00 80,000
2007-04-20 Estrada Vincent E (Sr VP and CFO) Sale 6,000 8.00 48,000
2007-04-20 Estrada Vincent E (Sr VP and CFO) Option Ex 6,000 1.80 10,800
2007-04-20 Sample Frank T (Chairman and CEO) Sale 10,000 8.00 80,000
2007-04-20 Sample Frank T (Chairman and CEO) Option Ex 10,000 .35 3,500
2007-03-23 Breslow Michael J (EVP Clinical R&D) Sale 816 8.00 6,528
2007-02-07 Sample Frank T (Chairman and CEO) Sale 5,000 10.88 54,410
2007-02-07 Sample Frank T (Chairman and CEO) Option Ex 5,000 .35 1,750
2007-02-01 Breslow Michael J (EVP Clinical R&D) Sale 10,000 10.34 103,400
2007-02-01 Rosenfeld Brian A (EVP and CMO) Sale 10,000 10.35 103,470
2007-02-01 Estrada Vincent E (Sr VP and CFO) Sale 4,000 10.34 41,340
2007-02-01 Estrada Vincent E (Sr VP and CFO) Option Ex 4,000 1.80 7,200
2007-01-03 Breslow Michael J (EVP Clinical R&D) Sale 10,000 10.58 103,532
2007-01-03 Rosenfeld Brian A (EVP and CMO) Sale 10,000 10.37 103,917
2007-01-03 Estrada Vincent E (Sr VP and CFO) Sale 4,000 10.47 41,864
2007-01-03 Estrada Vincent E (Sr VP and CFO) Option Ex 4,000 1.80 7,200
2007-01-03 Sample Frank T (Chairman and CEO) Sale 5,000 10.03 51,556
2007-01-03 Sample Frank T (Chairman and CEO) Option Ex 5,000 .35 1,750
2006-12-06 Sample Frank T (Chairman and CEO) Sale 5,000 10.04 50,220
2006-12-06 Sample Frank T (Chairman and CEO) Option Ex 5,000 .35 1,750
2006-12-01 Breslow Michael J (EVP Clinical R&D) Sale 10,000 10.00 100,000
2006-12-01 Rosenfeld Brian A (EVP and CMO) Sale 10,000 10.00 100,050
2006-12-01 Estrada Vincent E (Sr VP and CFO) Sale 4,000 10.00 40,000
2006-12-01 Estrada Vincent E (Sr VP and CFO) Option Ex 4,000 1.80 7,200
2006-11-30 Tatum Lisa Skeete (10% Owner) Sale 387,000 10.04 3,885,479
2006-11-30 Clarke John K (Director) Sale 387,000 10.04 3,885,479
2006-11-30 Sample Frank T (Chairman and CEO) Sale 20,000 10.00 200,000
2006-11-30 Sample Frank T (Chairman and CEO) Option Ex 20,000 .35 7,000
2006-11-28 Bronfein Michael G (Director) Buy 10,000 9.28 92,820
2006-11-16 Tatum Lisa Skeete (10% Owner) Sale 31,500 10.04 316,291
2006-11-16 Clarke John K (Director) Sale 31,500 10.04 316,386
2006-11-07 Breslow Michael J (EVP Clinical R&D) Sale 5,000 10.00 50,000
2006-11-07 Rosenfeld Brian A (EVP and CMO) Sale 10,000 10.14 101,359
2006-11-07 Estrada Vincent E (Sr VP and CFO) Sale 1,000 10.00 10,000
2006-11-07 Estrada Vincent E (Sr VP and CFO) Option Ex 1,000 1.80 1,800
2006-11-07 Sterling Venture Partners Llc (10% Owner) Sale 425,000 10.44 4,436,575
2006-11-07 Bronfein Michael G (Director) Sale 425,000 10.44 4,436,575
2006-11-03 Breslow Michael J (EVP Clinical R&D) Sale 5,000 9.34 46,705
2006-11-01 Estrada Vincent E (Sr VP and CFO) Sale 3,000 9.52 28,563
2006-11-01 Estrada Vincent E (Sr VP and CFO) Option Ex 3,000 1.80 5,400
2006-11-01 Sample Frank T (Chairman and CEO) Sale 5,000 9.54 47,699
2006-11-01 Sample Frank T (Chairman and CEO) Option Ex 5,000 .35 1,750
2006-04-05 Hull Brandon H (10% Owner) Buy 4,000 16.00 64,000
2006-04-05 Oakey James A (Director) Buy 3,000 16.00 48,000
2006-04-05 Sabin Ralph C (Director) Buy 2,250 16.00 36,000
2006-04-05 Altman Stuart H (Director) Buy 5,000 16.00 80,000

Insider trading activities including stock purchases, stock sales, and option exercises of EICU listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Visicu Inc (symbol EICU, CIK number 1166463) see the Securities and Exchange Commission (SEC) website.